Company / Total Assets
Spero Therapeutics, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$68.9M
FY2025
5-year range
$68.9M / $182.4M
FY2021-FY2025
Trend
-37.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $69M in FY2025 to $182M in FY2023.
Based on SEC 10-K filings.
$69M in FY2025 with a 5-year CAGR of -14.8%.
Declined from $182M to $69M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.0%
- 5-Year CAGR
- -14.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.8%, indicating a declining trend.
- In FY2025, total assets decreased 37.7% year-over-year.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.9M | -37.7% |
| FY2024 | $110.5M | -39.4% |
| FY2023 | $182.4M | +46.1% |
| FY2022 | $124.8M | -27.0% |
| FY2021 | $171.1M | +11.5% |
| FY2020 | $153.5M | +44.6% |
| FY2019 | $106.1M | -17.8% |
| FY2018 | $129.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026